Instruction for use: Smectite dioctaedric (Smectitum dioctaedricum)

Pharmacological group

Adsorbents

Antidiarrhoeic agents

Nosological classification (ICD-10)

K21 Gastroesophageal reflux

Biliary reflux esophagitis, gastrocardiac syndrome, Gastroesophageal reflux disease, Gastro-oesophageal reflux disease, Non-erosive reflux disease, syndrome gastrocardiac, Remhelda syndrome, Erosive reflux esophagitis, Ulcerative reflux esophagitis

K25 Gastric ulcer

Helicobacter pylori, Pain syndrome in gastric ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, Inflammation of the gastric mucosa, Inflammation of the gastrointestinal mucosa, Benign gastric ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Aggravation gastroduodenita on the background of peptic ulcer, Exacerbation of peptic ulcer, The aggravation of gastric ulcer, The organic gastrointestinal disease, Peptic ulcer of the stomach and duodenum, Postoperative gastric ulcer, Recurrent ulcers, Symptomatic gastric ulcers, Chronic inflammatory disease of the upper gastrointestinal tract, associated with Helicobacter pylori, Helicobacter pylori eradication, Erosive and ulcerative lesions of the stomach, Erosive lesions of the stomach, The erosion of the gastric mucosa, Peptic ulcer disease, Stomach ulcer, Gastric lesion, Ulcerative lesions of the stomach, Symptomatic ulcers of the stomach and duodenum

K26 Duodenal Ulcer

Pain with duodenal ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Exacerbation of peptic ulcer, The worsening of duodenal ulcer, Peptic ulcer of the stomach and duodenum, Relapse of duodenal ulcers, Symptomatic ulcers of the stomach and duodenum, Helicobacter pylori eradication, Erosive and ulcerative lesions of the duodenum, Erosive-ulcerative lesions of duodenal ulcers associated with Helicobacter pylori, Erosive lesions of the duodenum, Duodenal ulcer, Ulcerative lesions of the duodenum]

K29 Gastritis and duodenitis

Aggravation gastroduodenita on the background of peptic ulcer, duodenitis

K58 Irritable Bowel Syndrome

Irritable bowel syndrome, Colitis spastic, Irritable bowel syndrome, Irritable bowel syndrome is a thin, irritable bowel syndrome, colon irritation syndrome, Symptoms of irritable bowel, Irritation of the stomach, Irritation of the intestinal mucosa, Irritated colon

K59.1 Functional diarrhea

Diarrheal syndrome, Diarrhea, Diarrhea with prolonged enteral feeding through the probem, Prolonged diarrheam Nonspecific diarrhea, Acute diarrhea, Diarrhea, Syndrome of diarrhea, Functional diarrhea, Chronic diarrhea, Diarrhea with an electrolyte balance disorder, Chronic diarrhea, Diarrhea of non-infectious genesis, Diarrhea after a gastroectomy, Diarrhea in children, Persistent diarrhea, Diarrhea (diarrhea), Enterocolitis of non-infectious origin

Pharmacology

Pharmacological action - adsorbing, enveloping, gastroprotective, antidiarrheal.

Has a pronounced adsorbent (has a discoid-crystalline structure) and enveloping (due to a high level of fluidity) properties, has a protective effect on the mucous membrane of the esophagus, stomach and intestines (stabilizes the mucous barrier). Forms polyvalent bonds with mucus glycoproteins, increases the duration of mucus function and potentiates the protection of the gastrointestinal mucosa from the action of H + ions, bile salts, intestinal microorganisms, their toxins and other irritants. Characterized by a slight swelling effect. In therapeutic doses does not affect intestinal motility. It is not absorbed from the digestive tract, it is excreted from the body in unchanged form.

Application of Smectite diocaedric

Acute and chronic diarrhea, incl. in children; symptomatic therapy of pain syndrome with gastrointestinal diseases (esophagitis, gastroduodenitis, peptic ulcer and duodenal ulcer, colon disease, intestinal colic).

Contraindications

Hypersensitivity, intestinal obstruction.

pregnancy and lactation

possible

Side effects

Constipation.

Interaction

May decrease the rate and / or degree of absorption of other substances from the gastrointestinal tract (if necessary, the interval between doses should be 1-1.5 h).

Overdose

Data on cases of overdose are absent.

Routes of administration

Inside.

Precautions for Smectite diocaedric

If the pain is accompanied by fever or vomiting or persists after 7 days of treatment, a doctor's consultation is necessary.

special instructions

The development of constipation is a dose-related complication (it occurs when the dose is reduced) and does not prevent the continuation of treatment.